Long Term Stability, Survival and Tolerability of a (Novel) Baha® Implant System

NACompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Conductive Hearing Loss
Interventions
DEVICE

Novel Implant BI300

The Novel Implant BI300 was the new titanium implant and abutment for the Baha system developed by Cochlear Bone Anchored Solutions AB. The novel implant is 4.5 mm wide and 4.0 mm long.

DEVICE

Standard Implant BI300

The Standard Implant BI300 was the standard titanium implant and abutment in the Baha system developed by Cochlear Bone Anchored Solutions AB. The implant is 3.75 mm wide and 4.0 mm long

Trial Locations (4)

Unknown

Radboud University Medical Center, Nijmegen

Sahlgrenska University Hospital, Gothenburg

Manchester Royal Infirmary, Manchester

M6 8HD

Salford Royal hospital, Salford, Manchester

All Listed Sponsors
lead

Cochlear Bone Anchored Solutions

INDUSTRY

NCT02092610 - Long Term Stability, Survival and Tolerability of a (Novel) Baha® Implant System | Biotech Hunter | Biotech Hunter